| __timestamp | Halozyme Therapeutics, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22732000 | 54823000000 |
| Thursday, January 1, 2015 | 29245000 | 76691000000 |
| Friday, January 1, 2016 | 33206000 | 87477000000 |
| Sunday, January 1, 2017 | 31152000 | 89052000000 |
| Monday, January 1, 2018 | 10136000 | 100745000000 |
| Tuesday, January 1, 2019 | 45546000 | 91915000000 |
| Wednesday, January 1, 2020 | 43367000 | 95905000000 |
| Friday, January 1, 2021 | 81413000 | 104442000000 |
| Saturday, January 1, 2022 | 139304000 | 104437000000 |
| Sunday, January 1, 2023 | 192361000 | 112009000000 |
| Monday, January 1, 2024 | 159417000 | 121134000000 |
Data in motion
In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding cost structures is crucial. Walgreens Boots Alliance, Inc., a retail giant, and Halozyme Therapeutics, Inc., a biotech innovator, present a fascinating study in contrasts. From 2014 to 2023, Walgreens consistently reported a cost of revenue exceeding $50 billion annually, peaking at approximately $112 billion in 2023. This reflects its expansive retail operations and global reach. In contrast, Halozyme's cost of revenue, while significantly lower, has shown a remarkable growth trajectory, increasing nearly tenfold from 2014 to 2023. This surge underscores Halozyme's strategic investments in research and development, driving innovation in therapeutic solutions. Notably, data for 2024 is incomplete, highlighting the dynamic nature of financial reporting. This analysis offers a window into the strategic priorities and operational scales of two distinct industry players.
Novo Nordisk A/S vs Halozyme Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Johnson & Johnson vs Walgreens Boots Alliance, Inc.
Cost of Revenue Comparison: Amgen Inc. vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Zoetis Inc. vs Walgreens Boots Alliance, Inc.
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Halozyme Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Halozyme Therapeutics, Inc.'s Expenses
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Halozyme Therapeutics, Inc. and Pharming Group N.V.
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Mesoblast Limited's Expenses
Halozyme Therapeutics, Inc. vs Galapagos NV: Efficiency in Cost of Revenue Explored